ArticleJournal of microscopy and ultrastructure
Clear-Cell Variant of Ameloblastic Carcinoma: Pathological Insights for a more Specific Categorization.
Article in Journal of microscopy and ultrastructure. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The presence of clear cells is associated with the aggressiveness of the lesion and also poses a diagnostic dilemma. Hence, specific categorization of the lesion is of the utmost importance for therapeutic intervention. A 70-year-old male patient reported with a chief complaint of discomfort and swelling in the left mandibular alveolar region. Biopsy from the lesion was suggestive of ameloblastic carcinoma (AC) with clear-cell differentiation. The differential diagnosis of clear-cell components can be clear-cell odontogenic carcinoma, clear-cell adenocarcinoma of the salivary gland, mucoepidermoid carcinoma, and metastatic neoplasm. In the present case, the pathogenesis of this rare tumor is studied with the help of molecular markers such as p53, proliferating cell nuclear antigen, alpha-smooth muscle actin, vimentin, and p63 along with special stains such as periodic acid-Schiff, mucicarmine, and alcian blue. The clinical and biological behavior of these lesser-known variants has not been established due to the scarcity of meta-analysis and systematic reviews. Thus, this rare case of AC with clear-cell differentiation would highlight the pathogenesis, prognosis, and outcome of the disease with unusual histological presentation than conventional AC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.